本页面由Tiger Trade Technology Pte. Ltd.提供服务

Rocket Pharmaceuticals, Inc.

2.33
-0.1544-6.23%
成交量:273.62万
成交额:636.16万
市值:2.55亿
市盈率:-13.68
高:2.55
开:2.47
低:2.26
收:2.48
52周最高:5.45
52周最低:2.26
股本:1.10亿
流通股本:8,539.15万
量比:1.09
换手率:3.20%
股息:- -
股息率:- -
每股收益(TTM):-0.1700
每股收益(LYR):-2.0100
净资产收益率:-4.77%
总资产收益率:-28.42%
市净率:0.69
市盈率(LYR):-1.16

数据加载中...

2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/12

重要事件披露

Form 8-K - Current report
2024/12/05

重要事件披露

Form 8-K - Current report
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report